Published in Nature on January 16, 1992
Copy number variation in human health, disease, and evolution. Annu Rev Genomics Hum Genet (2009) 7.64
K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension. Science (2011) 5.40
The molecular biology, biochemistry, and physiology of human steroidogenesis and its disorders. Endocr Rev (2010) 4.95
Detection of clinically relevant exonic copy-number changes by array CGH. Hum Mutat (2010) 2.93
A novel form of human mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism. J Clin Endocrinol Metab (2008) 2.48
A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest (1997) 2.23
The Genetic Basis of Mendelian Phenotypes: Discoveries, Challenges, and Opportunities. Am J Hum Genet (2015) 2.22
Molecular phenotyping for analyzing subtle genetic effects in mice: application to an angiotensinogen gene titration. Proc Natl Acad Sci U S A (2002) 2.08
Genetics of human cardiovascular disease. Cell (2012) 1.90
Genome destabilization by homologous recombination in the germ line. Nat Rev Mol Cell Biol (2010) 1.76
Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5. Proc Natl Acad Sci U S A (2012) 1.74
An SGK1 site in WNK4 regulates Na+ channel and K+ channel activity and has implications for aldosterone signaling and K+ homeostasis. Proc Natl Acad Sci U S A (2007) 1.65
Kelch-like 3 and Cullin 3 regulate electrolyte homeostasis via ubiquitination and degradation of WNK4. Proc Natl Acad Sci U S A (2013) 1.56
Hypertension in mice lacking 11beta-hydroxysteroid dehydrogenase type 2. J Clin Invest (1999) 1.55
Chromosomal duplications in bacteria, fruit flies, and humans. Am J Hum Genet (1996) 1.45
Genetic determinants of human hypertension. Proc Natl Acad Sci U S A (1995) 1.37
Human cytochromes P450 in health and disease. Philos Trans R Soc Lond B Biol Sci (2013) 1.36
Genetics of congenital adrenal hyperplasia. Best Pract Res Clin Endocrinol Metab (2009) 1.33
Complementation of reduced survival, hypotension, and renal abnormalities in angiotensinogen-deficient mice by the human renin and human angiotensinogen genes. J Clin Invest (1997) 1.29
Mineralocorticoid receptors: distribution and activation. Heart Fail Rev (2005) 1.28
Glucocorticoid-suppressible hyperaldosteronism results from hybrid genes created by unequal crossovers between CYP11B1 and CYP11B2. Proc Natl Acad Sci U S A (1992) 1.23
Positional identification of variants of Adamts16 linked to inherited hypertension. Hum Mol Genet (2009) 1.21
Role of KCNJ5 in familial and sporadic primary aldosteronism. Nat Rev Endocrinol (2012) 1.20
Tree-structured supervised learning and the genetics of hypertension. Proc Natl Acad Sci U S A (2004) 1.17
The genetics of microdeletion and microduplication syndromes: an update. Annu Rev Genomics Hum Genet (2014) 1.16
Mutations in the CYP11B1 gene causing congenital adrenal hyperplasia and hypertension cluster in exons 6, 7, and 8. Proc Natl Acad Sci U S A (1993) 1.14
Measurement and interpretation of blood pressure. Arch Dis Child (2000) 1.11
Alu-specific microhomology-mediated deletion of the final exon of SPAST in three unrelated subjects with hereditary spastic paraplegia. Genet Med (2011) 1.08
A gene differentially expressed in the kidney of the spontaneously hypertensive rat cosegregates with increased blood pressure. J Clin Invest (1993) 1.07
Genes for blood pressure: an opportunity to understand hypertension. Eur Heart J (2013) 1.07
A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22). J Med Genet (2000) 1.07
Mendelian forms of human hypertension and mechanisms of disease. Clin Med Res (2003) 1.06
Detection of copy-number variation in AUTS2 gene by targeted exonic array CGH in patients with developmental delay and autistic spectrum disorders. Eur J Hum Genet (2012) 1.03
Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism. Elife (2015) 1.01
Identification of the UBP1 locus as a critical blood pressure determinant using a combination of mouse and human genetics. PLoS Genet (2009) 1.00
Genetics of hypertension: from experimental animals to humans. Biochim Biophys Acta (2009) 1.00
Structural variation mutagenesis of the human genome: Impact on disease and evolution. Environ Mol Mutagen (2015) 1.00
Af17 deficiency increases sodium excretion and decreases blood pressure. J Am Soc Nephrol (2011) 1.00
Regulation and dysregulation of epithelial Na+ channels. Clin Exp Nephrol (2011) 0.98
Heritable forms of hypertension. Pediatr Nephrol (2007) 0.98
Genetics of arterial hypertension and hypotension. Naunyn Schmiedebergs Arch Pharmacol (2007) 0.97
Mechanisms of hypertension: the expanding role of aldosterone. J Am Soc Nephrol (2004) 0.95
The use of plasma aldosterone and urinary sodium to potassium ratio as translatable quantitative biomarkers of mineralocorticoid receptor antagonism. J Transl Med (2011) 0.93
Molecular mechanisms of experimental salt-sensitive hypertension. J Am Heart Assoc (2012) 0.90
Mouse chromosome engineering for modeling human disease. Annu Rev Genomics Hum Genet (2006) 0.90
Overview of the genetic determinants of primary aldosteronism. Appl Clin Genet (2014) 0.88
Diagnosis of diseases of steroid hormone production, metabolism and action. J Clin Res Pediatr Endocrinol (2009) 0.88
Laboratory investigation of primary aldosteronism. Clin Biochem Rev (2010) 0.88
Genomics of heart failure. Heart Fail Clin (2010) 0.87
Molecular mechanism of transcriptional activation of angiotensinogen gene by proximal promoter. J Clin Invest (1994) 0.87
Minireview: potassium channels and aldosterone dysregulation: is primary aldosteronism a potassium channelopathy? Endocrinology (2013) 0.87
Blood pressure and human genetic variation in the general population. Curr Opin Cardiol (2010) 0.85
Glucocorticoid-suppressible hyperaldosteronism and adrenal tumors occurring in a single French pedigree. J Clin Invest (1995) 0.85
Renal tubular transport and the genetic basis of hypertensive disease. Clin Exp Nephrol (2005) 0.85
Matching the right drug to the right patient in essential hypertension. Heart (2001) 0.84
Association of angiotensin II type 1 receptor (A1166C) gene polymorphism and its increased expression in essential hypertension: a case-control study. PLoS One (2014) 0.84
A practical approach to genetic hypokalemia. Electrolyte Blood Press (2010) 0.84
Dissection of a quantitative trait locus for genetic hypertension on rat chromosome 10. Proc Natl Acad Sci U S A (1995) 0.84
Understanding primary aldosteronism: impact of next generation sequencing and expression profiling. Mol Cell Endocrinol (2014) 0.83
Measurement of peripheral plasma 18-oxocortisol can discriminate unilateral adenoma from bilateral diseases in patients with primary aldosteronism. Hypertension (2015) 0.81
Different effects of progesterone and estradiol on chimeric and wild type aldosterone synthase in vitro. Reprod Biol Endocrinol (2013) 0.81
Pivotal role of the kidney in hypertension. Am J Med Sci (2010) 0.81
Genetics of hypertension: discoveries from the bench to human populations. Am J Physiol Renal Physiol (2013) 0.80
Effects of aldosterone and mineralocorticoid receptor blockade on intracellular electrolytes. Heart Fail Rev (2005) 0.80
A diagnostic approach for the child with hypertension. Pediatr Nephrol (2005) 0.80
Diagnosis and management of primary aldosteronism. World J Surg (2003) 0.80
The kidneys and aldosterone/mineralocorticoid receptor system in salt-sensitive hypertension. Curr Hypertens Rep (2011) 0.79
Studies on the origin of circulating 18-hydroxycortisol and 18-oxocortisol in normal human subjects. J Clin Endocrinol Metab (2004) 0.79
Pseudoaldosteronism induced by Yokukansan in an elderly Japanese type 2 diabetic patient with Alzheimer's disease. J Diabetes Investig (2015) 0.79
Aldosterone and cortisol co-secreting bifunctional adrenal cortical carcinoma: A rare event. Indian J Urol (2014) 0.78
The molecular basis of blood pressure variation. Pediatr Nephrol (2012) 0.78
Four is not more than two. Am J Hum Genet (1995) 0.78
Monogenic forms of hypertension. Eur J Pediatr (2011) 0.78
Disordered zonal and cellular CYP11B2 enzyme expression in familial hyperaldosteronism type 3. Mol Cell Endocrinol (2016) 0.78
Variation of phenotype in patients with glucocorticoid remediable aldosteronism. J Med Genet (1996) 0.77
Physiologic tailoring of treatment in resistant hypertension. Curr Cardiol Rev (2010) 0.77
Beta-2 adrenoreceptor gene polymorphisms and sympathetic outflow in humans. Clin Auton Res (2011) 0.77
Adrenal Mitochondria and Steroidogenesis: From Individual Proteins to Functional Protein Assemblies. Front Endocrinol (Lausanne) (2016) 0.76
Hyperaldosteronism: recent concepts, diagnosis, and management. Postgrad Med J (2001) 0.76
Regulatory mechanism of "K+recycling" for Na +reabsorption in renal tubules. Clin Exp Nephrol (2007) 0.76
The diagnosis of Liddle syndrome by identification of a mutation in the beta subunit of the epithelial sodium channel. J Med Genet (1998) 0.75
Genetic analyses of the chimeric CYP11B1/CYP11B2 gene in a Korean family with glucocorticoid-remediable aldosteronism. J Korean Med Sci (2010) 0.75
Rapid diagnosis of glucocorticoid suppressible hyperaldosteronism in infants and adolescents. Arch Dis Child (1994) 0.75
Effects of Chronic ACTH Excess on Human Adrenal Cortex. Front Endocrinol (Lausanne) (2017) 0.75
Genetics of primary aldosteronism. Endocr Pract (2015) 0.75
The Potential of ACTH in the Genesis of Primary Aldosteronism. Front Endocrinol (Lausanne) (2016) 0.75
Discovery of Potential Inhibitors of Aldosterone Synthase from Chinese Herbs Using Pharmacophore Modeling, Molecular Docking, and Molecular Dynamics Simulation Studies. Biomed Res Int (2016) 0.75
Gene mutations that promote adrenal aldosterone production, sodium retention, and hypertension. Appl Clin Genet (2013) 0.75
Why some people prefer pickle juice: the research of Dr. Richard P. Lifton. Yale J Biol Med (2007) 0.75
Mineralocorticoid Excess or Glucocorticoid Insufficiency: Renal and Metabolic Phenotypes in a Rat Hsd11b2 Knockout Model. Hypertension (2015) 0.75
Adrenal Diagnostics: An Endocrinologist's Perspective focused on Hyperaldosteronism. Clin Biochem Rev (2013) 0.75
Investigation of hypertension and the recognition of monogenic hypertension. Arch Dis Child (1999) 0.75
Familial hyperaldosteronism type III. J Hum Hypertens (2017) 0.75
Primary aldosteronism: are we diagnosing and operating on too few patients? World J Surg (2001) 0.75
DIAGNOSIS OF ENDOCRINE DISEASE: 18-Oxocortisol and 18-Hydroxycortisol. Is there clinical utility of these steroids? Eur J Endocrinol (2017) 0.75
Adrenal GIPR expression and chromosome 19q13 microduplications in GIP-dependent Cushing's syndrome. JCI Insight (2017) 0.75
Role of genetic factors in the etiopathogenesis of cerebrovascular accidents: from an animal model to the human disease. Cell Mol Neurobiol (2004) 0.75
Multilocus linkage analysis in humans: detection of linkage and estimation of recombination. Am J Hum Genet (1985) 87.59
Strategies for multilocus linkage analysis in humans. Proc Natl Acad Sci U S A (1984) 48.41
Easy calculations of lod scores and genetic risks on small computers. Am J Hum Genet (1984) 28.51
Centre d'etude du polymorphisme humain (CEPH): collaborative genetic mapping of the human genome. Genomics (1990) 13.23
Construction of human linkage maps: likelihood calculations for multilocus linkage analysis. Genet Epidemiol (1986) 8.95
A closely linked genetic marker for cystic fibrosis. Nature (1985) 7.85
Resolution of linkage for irregular phenotype systems. Hum Hered (1981) 6.99
Report of the Committee on the Genetic Constitution of Chromosomes 17, 18 and 19. Cytogenet Cell Genet (1985) 6.88
Molecular basis of human hypertension: role of angiotensinogen. Cell (1992) 6.07
A unified model for complex segregation analysis. Am J Hum Genet (1983) 5.67
Report of the Committee on Methods of Linkage Analysis and Reporting. Cytogenet Cell Genet (1985) 5.61
Complex segregation analysis with pointers. Hum Hered (1981) 5.59
Liddle's syndrome: heritable human hypertension caused by mutations in the beta subunit of the epithelial sodium channel. Cell (1994) 5.29
A maximum likelihood map of chromosome 1. Am J Hum Genet (1979) 4.34
Linkage mapping from pair-wise recombination data. Heredity (Edinb) (1977) 4.32
A primary genetic map of markers of human chromosome 10. Genomics (1988) 4.23
A primary genetic map of chromosome 13q. Am J Hum Genet (1986) 4.01
Linkage of cystic fibrosis to two tightly linked DNA markers: joint report from a collaborative study. Am J Hum Genet (1986) 3.83
A mapped set of DNA markers for human chromosome 17. Genomics (1988) 3.55
Efficient computations in multilocus linkage analysis. Am J Hum Genet (1988) 3.39
250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study. Lancet Neurol (2009) 3.37
Elements of a paracrine tubular renin-angiotensin system along the entire nephron. Hypertension (1999) 3.33
Privacy and security of personal information in a new health care system. JAMA (1993) 3.29
Genotyping and sequence analysis of apolipoprotein E isoforms. Genomics (1988) 3.20
Isolation and mapping of a polymorphic DNA sequence (pTHH22) on chromosome 9 [D9S12]. Nucleic Acids Res (1988) 3.17
How the doctor got gagged. The disintegrating right of privacy in the physician-patient relationship. JAMA (1991) 3.05
Molecular phylogeny and evolutionary timescale for the family of mammalian herpesviruses. J Mol Biol (1995) 2.84
A mapped set of genetic markers for human chromosome 9. Genomics (1988) 2.80
Quality of diabetes care in community health centers. Am J Public Health (2000) 2.76
Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase. Circulation (2001) 2.64
Diagnosis and treatment of primary hyperaldosteronism. Ann Intern Med (1994) 2.62
Oxidative damage to DNA in diabetes mellitus. Lancet (1996) 2.54
Combined linkage and segregation analysis using regressive models. Am J Hum Genet (1988) 2.33
Genetic analysis of an inherited predisposition to colon cancer in a family with a variable number of adenomatous polyps. N Engl J Med (1990) 2.32
A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest (1997) 2.23
The PATHWAYS church-based weight loss program for urban African-American women at risk for diabetes. Diabetes Care (1997) 2.16
A detailed genetic map of the long arm of chromosome 11. Genomics (1990) 2.11
Molecular phylogeny of the alphaherpesvirinae subfamily and a proposed evolutionary timescale. J Mol Biol (1994) 2.09
Multiple organ carcinogenicity of 1,3-butadiene in B6C3F1 mice after 60 weeks of inhalation exposure. Science (1985) 2.09
The CEPH consortium linkage map of human chromosome 1. Genomics (1991) 2.09
Robustness and power of the unified model in the analysis of quantitative measurements. Am J Hum Genet (1986) 1.98
Tests of gene order from three-locus linkage data. Ann Hum Genet (1987) 1.87
Patients' attitudes about autonomy and confidentiality in genetic testing for breast-ovarian cancer susceptibility. Am J Med Genet (1997) 1.82
Captopril-induced changes in prostaglandin production: relationship to vascular responses in normal man. J Clin Invest (1980) 1.76
Characterization of eight VNTR loci by agarose gel electrophoresis. Genomics (1989) 1.74
Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation (1995) 1.73
Linkage, physical mapping, and DNA sequence analysis of pseudoautosomal loci on the human X and Y chromosomes. Genomics (1987) 1.70
A systematic study of HLA class II-beta DNA restriction fragments in insulin-dependent diabetes mellitus. Proc Natl Acad Sci U S A (1985) 1.69
Tightly linked markers for the neurofibromatosis type 1 gene. Genomics (1987) 1.68
Adenosine 3':5'-cyclic monophosphate as a regulator of bacterial transformation. Proc Natl Acad Sci U S A (1973) 1.67
Tip60 is a nuclear hormone receptor coactivator. J Biol Chem (1999) 1.67
Up-regulated p75NTR neurotrophin receptor on glial cells in MS plaques. Neurology (1999) 1.64
Neuroendocrine function and response to stress in mice with complete disruption of glucagon-like peptide-1 receptor signaling. Endocrinology (2000) 1.63
Clinical reactogenicity of intradermal bacille Calmette-Guérin vaccination. Clin Infect Dis (1999) 1.59
Missense mutation (Gly----Glu188) of human lipoprotein lipase imparting functional deficiency. J Biol Chem (1990) 1.57
Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase. Nat Genet (1992) 1.55
Barriers to providing diabetes care in community health centers. Diabetes Care (2001) 1.52
Isolation and mapping of a polymorphic DNA sequence pYNH24 on chromosome 2 (D2S44). Nucleic Acids Res (1987) 1.51
Isolation and mapping of a polymorphic DNA sequence pYNZ86.1 on chromosome 3 (D3S30). Nucleic Acids Res (1987) 1.48
Isolation and mapping of a polymorphic DNA sequence (pEFD145) on chromosome 3 [D3S32]. Nucleic Acids Res (1988) 1.47
Impaired potassium-stimulated aldosterone production: a possible explanation for normokalemic glucocorticoid-remediable aldosteronism. J Clin Endocrinol Metab (1997) 1.46
1997 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. Am J Emerg Med (1998) 1.46
Isolation and mapping of a polymorphic DNA sequence (pYNZ22) on chromosome 17p [D17S30]. Nucleic Acids Res (1988) 1.44
Genetic counseling in sex linkage. Birth Defects Orig Artic Ser (1979) 1.43
Height, weight and age at menarche and the "critical weight" hypothesis. Science (1971) 1.43
Twenty-eight loci form a continuous linkage map of markers for human chromosome 1. Genomics (1989) 1.40
The nucleotide sequence of the env gene from the human provirus ERV3 and isolation and characterization of an ERV3-specific cDNA. Virology (1985) 1.40
Benign familial neonatal convulsions linked to genetic markers on chromosome 20. Nature (1989) 1.40
Premature menopause: monoclonal antibody defined T lymphocyte abnormalities and antiovarian antibodies. Fertil Steril (1989) 1.39
Tolerance for depression: are there cultural and gender differences? J Psychiatr Ment Health Nurs (2002) 1.39
Mapping recessive ophthalmic diseases: linkage of the locus for Usher syndrome type II to a DNA marker on chromosome 1q. Genomics (1990) 1.38
Androgen receptor nuclear translocation is facilitated by the f-actin cross-linking protein filamin. Mol Endocrinol (2000) 1.38
Replacements of Pro86 in phage T4 lysozyme extend an alpha-helix but do not alter protein stability. Science (1988) 1.37
Detection of linkage between a quantitative trait and a marker locus by the lod score method: sample size and sampling considerations. Ann Hum Genet (1988) 1.35
Involvement of the CD95 (APO-1/Fas) receptor/ligand system in multiple sclerosis brain. J Exp Med (1996) 1.34
Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nat Genet (1992) 1.34
Search for neutrinoless double-beta decay in 136Xe with EXO-200. Phys Rev Lett (2012) 1.33
Genetic epidemiology of Lesch-Nyhan disease. Am J Hum Genet (1977) 1.33
Lipoprotein lipase. Molecular model based on the pancreatic lipase x-ray structure: consequences for heparin binding and catalysis. J Biol Chem (1994) 1.33
Clusters of HLA class II beta restriction fragments describe allelic series. Proc Natl Acad Sci U S A (1984) 1.32
Contribution of prostaglandins to the antihypertensive action of captopril in essential hypertension. Hypertension (1981) 1.31
Genetic linkage between lipoprotein(a) phenotype and a DNA polymorphism in the plasminogen gene. Genomics (1988) 1.31
Direct detection and automated sequencing of individual alleles after electrophoretic strand separation: identification of a common nonsense mutation in exon 9 of the human lipoprotein lipase gene. Nucleic Acids Res (1990) 1.29
Evidence of genetic heterogeneity in five kindreds with familial hypertrophic cardiomyopathy. Circulation (1992) 1.29
Isolation and mapping of a polymorphic DNA sequence pHHH202 on chromosome 17 [D17S33]. Nucleic Acids Res (1988) 1.27
Nutrition Practice Guidelines for Type 1 Diabetes Mellitus positively affect dietitian practices and patient outcomes. The Diabetes Care and Education Dietetic Practice Group. J Am Diet Assoc (1998) 1.27
An extended genetic linkage map of markers for human chromosome 10. Genomics (1988) 1.26
Linkage studies in spinocerebellar ataxia (SCA). Am J Med Genet (1980) 1.25
Etiological heterogeneity in X-linked spastic paraplegia. Am J Hum Genet (1987) 1.25
Familial dyslipidemic hypertension. Evidence from 58 Utah families for a syndrome present in approximately 12% of patients with essential hypertension. JAMA (1988) 1.25
Propofol infusion in children. BMJ (1992) 1.24
Frequent recombination is observed in the distal end of the long arm of chromosome 14. Genomics (1989) 1.24
Genetic linkage and heterogeneity in type I Charcot-Marie-Tooth disease (hereditary motor and sensory neuropathy type I). Am J Hum Genet (1990) 1.24
Converting enzyme inhibition in essential hypertension: the hypotensive response does not reflect only reduced angiotensin II formation. Hypertension (1981) 1.23
Haplotypes of angiotensinogen in essential hypertension. Am J Hum Genet (1997) 1.23
Group Y incompatibility and copy control of P1 prophage. Plasmid (1981) 1.23